- Pharmaceutical companies are stockpiling medicines due to ongoing uncertainty over what will happen in Northern Ireland after Brexit.
- The UK government last month threatened to rip up its Brexit withdrawal agreement with the EU and has warned that no trade deal may be agreed with the EU by the end of the year.
- As a result, the industry says they “just don’t know” whether there will need to be checks on medicine going from Great Britain to Northern Ireland from next year.
- “We just don’t know how it’ll work in Northern Ireland,” the ABPI’s Richard Torbett told Business Insider.
- Visit Business Insider’s homepage for more stories.
Pharmaceutical companies are building up stockpiles of medicines to supply Northern Ireland due to widespread industry uncertainty over whether medicines will be allowed to move smoothly across the Irish Sea after Brexit.
With less than three months until the Brexit transition period ends, the